Let the immune cell see the virus: Scientists discover unique way to target common virus

February 15, 2021

Scientists at Cardiff University have discovered a unique way to target a common virus that affects one in 200 newborn babies in the UK but for which there is only limited treatments available.

Human cytomegalovirus (HCMV) is a master at "hiding" from the body's immune system so antibodies and T-cells cannot attack it as they do in other viruses, like the current coronavirus.

The researchers have now discovered a new type of antibody in the lab which - instead of killing the virus directly - marks infected cells so the immune system can "see" them.

Once the immune system can see the infected cells it is able to kill the virus.

The team have submitted a patent for the unique immunotherapeutic and hope it can help to treat HCMV, which can leave newborn babies severely disabled or even kill them.

Further work is needed to make sure it is safe and effective in humans - but the researchers hope the technique could eventually be used to fight other infectious diseases and the method they used to find the new antibody could be applied to cancer.

The study is published today in the Journal of Clinical Investigation.

Lead author Dr Richard Stanton, a virologist from Cardiff University's Division of Infection and Immunity, said: "HCMV is a major challenge because it has evolved a range of different techniques to avoid the body's own immune response.

"We have developed a really unique way of letting the immune system see the virus so it can get on with its task of killing it."

HCMV causes lifelong infection in humans and is a significant cause of severe disease or death in immunocompromised individuals, such as those undergoing transplants or people with HIV.

A vaccine is paramount to fighting the virus, particularly for tackling congenital disease, however there is currently no vaccine and only limited treatment options are available.

In this study, the researchers looked at whether antibody-dependent cellular cytotoxicity (ADCC) - a particular type of immune response in which a target cell is coated with antibodies and killed by immune cells - could be exploited for therapeutic use.

They used a special technique (proteomics) to characterise the molecules found on the surface of the infected cell and combined this with immunological screening to identify targets for ADCC.

They found a unique target expressed early in the virus's lifecycle and were then able to develop human antibodies for use against this target.

In the lab, this brought about a potent activation of ADCC, killing the infected cells.

"The identification of novel ADCC targets not only opens up a fuller understanding of natural immunity against HCMV that can be exploited for therapeutic benefit, but this could also now be applied to other infectious diseases - and the mechanism we used to pinpoint the new antibody could potentially also work in cancer," said Dr Stanton.

"Further work is now needed to demonstrate both safety and efficacy in humans."
* The study, Monoclonal antibodies targeting non-structural viral antigens can activate ADCC against human cytomegalovirus, can be accessed here as a PDF and will be available here after the embargo has passed

* Dr Richard Stanton is available for interview

For further information and interview requests contact:

* Gerry Holt, comms & marketing, Cardiff University - 029 2087 5596 or HoltG2@cardiff.ac.uk

Cardiff University is recognised in independent government assessments as one of Britain's leading teaching and research universities and is a member of the Russell Group of the UK's most research intensive universities. The 2014 Research Excellence Framework ranked the University 5th in the UK for research excellence. Among its academic staff are two Nobel Laureates, including the winner of the 2007 Nobel Prize for Medicine, Professor Sir Martin Evans. Founded by Royal Charter in 1883, today the University combines impressive modern facilities and a dynamic approach to teaching and research. The University's breadth of expertise encompasses: the College of Arts, Humanities and Social Sciences; the College of Biomedical and Life Sciences; and the College of Physical Sciences and Engineering, along with a longstanding commitment to lifelong learning. Cardiff's flagship Research Institutes are offering radical new approaches to pressing global problems. More at http://www.cardiff.ac.uk

Cardiff University

Related Immune System Articles from Brightsurf:

How the immune system remembers viruses
For a person to acquire immunity to a disease, T cells must develop into memory cells after contact with the pathogen.

How does the immune system develop in the first days of life?
Researchers highlight the anti-inflammatory response taking place after birth and designed to shield the newborn from infection.

Memory training for the immune system
The immune system will memorize the pathogen after an infection and can therefore react promptly after reinfection with the same pathogen.

Immune system may have another job -- combatting depression
An inflammatory autoimmune response within the central nervous system similar to one linked to neurodegenerative diseases such as multiple sclerosis (MS) has also been found in the spinal fluid of healthy people, according to a new Yale-led study comparing immune system cells in the spinal fluid of MS patients and healthy subjects.

COVID-19: Immune system derails
Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction - rather, the immune response is caught in a continuous loop of activation and inhibition.

Immune cell steroids help tumours suppress the immune system, offering new drug targets
Tumours found to evade the immune system by telling immune cells to produce immunosuppressive steroids.

Immune system -- Knocked off balance
Instead of protecting us, the immune system can sometimes go awry, as in the case of autoimmune diseases and allergies.

Too much salt weakens the immune system
A high-salt diet is not only bad for one's blood pressure, but also for the immune system.

Parkinson's and the immune system
Mutations in the Parkin gene are a common cause of hereditary forms of Parkinson's disease.

How an immune system regulator shifts the balance of immune cells
Researchers have provided new insight on the role of cyclic AMP (cAMP) in regulating the immune response.

Read More: Immune System News and Immune System Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.